Listen "CRISPR: developing an equitable technology amidst a global pandemic"
Episode Synopsis
In this episode, I speak to Geoffrey Siwo about CRISPR and the challenges facing its development into a technique that can be applied equitably across the globe. Geoffrey talks about the importance of seizing the opportunity to influence the progress of the embryonic gene-editing technology for the better, before the data bias in genomic data and the disparity in researchers working on the technique leads to ingrained differences in the success of the application in different populations. The impact of the COVID-19 pandemic on this development is also exposed.We also discuss Geoffrey's work, using CISPR in antiviral research to as a way of identifying small molecules capable of inducing broad-spectrum antiviral responses, with the potential to combat SARS-CoV-2. Tune in to find out how Geoffrey believes we can develop CRISPR to be a truly equitable technology and to hear just how hopeful he is for the future of the technique. *The Talking Techniques podcast is hosted and produced by Tristan Free for BioTechniques. We would love to here more from our listeners about your opinions on the podcast, what you would like to hear more of and what you think we could do better!Please get in contact on any of the platforms below.Twitter: @TristanFreefsgEmail: [email protected] Hosted on Acast. See acast.com/privacy for more information.
More episodes of the podcast Talking Techniques
Cytokine networks in autoimmune diseases: mechanisms, pathogenesis and therapeutic innovations
19/06/2025
Cytokines: from therapeutics to diagnostics
10/07/2024
Rare disease and pharmacogenomics
23/01/2024
One man’s waste in another man’s treasure: using wastewater to monitor infectious diseases
18/12/2023
Next-generation antibody therapeutics
22/11/2023
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.